Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
April 21, 2024
[Video-assisted Thoracoscopic Surgery for Chest Trauma]
Osamu Kakazu, Morio Ohta, Tetsuo Touyama
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
July 20, 2023
[Three-dimensional and 4K Three-dimensional Uniportal Video-assisted Thoracoscopic Surgery for Mediastinal and Chest Wall Disease During Respiratory Surgery]
Morio Ohta, Osamu Kakazu, Tetsuo Touyama
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
October 2, 2012
[Single-incision thoracoscopic surgery( SITS) for mediastinal disease]
Morio Ohta, Osamu Kakazu, Tetsuo Touyama, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
December 8, 2021
[Palmar Hyperhidrosis Associated with the Azygos Lobe]
Osamu Kakazu, Morio Ohta, Tomonari Shiohira, et al.
World Journal of Surgery
|
March 31, 2010
Partial breast reconstruction for an inferomedial breast carcinoma using an omental flap
Hisamitsu Zaha, Hiroki Sunagawa, Kouji Kawakami, et al.
International Journal of Clinical Oncology
|
July 6, 2016
Erratum to: UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer
Yoshinori Miyata, Tetsuo Touyama, Takaya Kusumi, et al.
International Journal of Clinical Oncology
|
December 30, 2015
UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer
Yoshinori Miyata, Tetsuo Touyama, Takaya Kusumi, et al.
International Journal of Clinical Oncology
|
September 5, 2015
A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)
Yutaka Ogata, Mototsugu Shimokawa, Takaho Tanaka, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2015
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
Masahito Kotaka, Takayuki Yoshino, Koji Oba, et al.
International Journal of Clinical Oncology
|
June 4, 2015
Phase II trial of an alternating regimen consisting of first-line mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: FIREFOX plus bevacizumab trial (KSCC0801)
Keisuke Miwa, Eiji Oki, Yasunori Emi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
April 21, 2024
[Video-assisted Thoracoscopic Surgery for Chest Trauma]
Osamu Kakazu, Morio Ohta, Tetsuo Touyama
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
July 20, 2023
[Three-dimensional and 4K Three-dimensional Uniportal Video-assisted Thoracoscopic Surgery for Mediastinal and Chest Wall Disease During Respiratory Surgery]
Morio Ohta, Osamu Kakazu, Tetsuo Touyama
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
October 2, 2012
[Single-incision thoracoscopic surgery( SITS) for mediastinal disease]
Morio Ohta, Osamu Kakazu, Tetsuo Touyama, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
December 8, 2021
[Palmar Hyperhidrosis Associated with the Azygos Lobe]
Osamu Kakazu, Morio Ohta, Tomonari Shiohira, et al.
World Journal of Surgery
|
March 31, 2010
Partial breast reconstruction for an inferomedial breast carcinoma using an omental flap
Hisamitsu Zaha, Hiroki Sunagawa, Kouji Kawakami, et al.
International Journal of Clinical Oncology
|
July 6, 2016
Erratum to: UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer
Yoshinori Miyata, Tetsuo Touyama, Takaya Kusumi, et al.
International Journal of Clinical Oncology
|
December 30, 2015
UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer
Yoshinori Miyata, Tetsuo Touyama, Takaya Kusumi, et al.
International Journal of Clinical Oncology
|
September 5, 2015
A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)
Yutaka Ogata, Mototsugu Shimokawa, Takaho Tanaka, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2015
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
Masahito Kotaka, Takayuki Yoshino, Koji Oba, et al.
International Journal of Clinical Oncology
|
June 4, 2015
Phase II trial of an alternating regimen consisting of first-line mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: FIREFOX plus bevacizumab trial (KSCC0801)
Keisuke Miwa, Eiji Oki, Yasunori Emi, et al.
Page
of 2